# OnCo record juventas-cell-therapy (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/juventas-cell-therapy/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "juventas-cell-therapy" ;
  schema:name "Juventas Cell Therapy"@en ;
  schema:alternateName "Hebei Senlang Biotechnology"@en ;
  schema:description "Juventas Cell Therapy in Tianjin developed inaticabtagene autoleucel, the first CAR-T approved in China for leukaemia (2023)."@en ;
  schema:url <https://onco.cc/companies/juventas-cell-therapy/>, <https://www.juventascell.com> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://www.juventascell.com> ;
  onco:tag "ctgov-sponsor", "china" ;
  schema:addressCountry "CN" ;
  onco:cancers <https://onco.cc/cancers/all-leukemia/> ;
  onco:technologies <https://onco.cc/technologies/car-t/> ;
  onco:drugs <https://onco.cc/drugs/inaticabtagene-autoleucel/> ;
  onco:trials <https://onco.cc/trials/nct05667506/>, <https://onco.cc/trials/nct04684147/>, <https://onco.cc/trials/nct04586478/> .